| Product Code: ETC9683429 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Drug-Resistant Epilepsy Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Drug-Resistant Epilepsy Market - Industry Life Cycle |
3.4 Thailand Drug-Resistant Epilepsy Market - Porter's Five Forces |
3.5 Thailand Drug-Resistant Epilepsy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Thailand Drug-Resistant Epilepsy Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Thailand Drug-Resistant Epilepsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of drug-resistant epilepsy in Thailand |
4.2.2 Growing awareness and diagnosis of epilepsy in the country |
4.2.3 Advancements in treatment options and technologies for drug-resistant epilepsy |
4.3 Market Restraints |
4.3.1 Limited accessibility to specialized epilepsy care centers in Thailand |
4.3.2 High costs associated with advanced epilepsy treatments |
4.3.3 Lack of reimbursement policies for expensive anti-epileptic drugs |
5 Thailand Drug-Resistant Epilepsy Market Trends |
6 Thailand Drug-Resistant Epilepsy Market, By Types |
6.1 Thailand Drug-Resistant Epilepsy Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Neuromodulation Therapy, 2021- 2031F |
6.1.4 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Antiseizure Medications, 2021- 2031F |
6.1.5 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.1.6 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Resective Epilepsy Surgery, 2021- 2031F |
6.1.7 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Specific Metabolic Treatment, 2021- 2031F |
6.1.8 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Specific Genetic Treatment, 2021- 2031F |
6.2 Thailand Drug-Resistant Epilepsy Market, By End-users |
6.2.1 Overview and Analysis |
6.2.2 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Thailand Drug-Resistant Epilepsy Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Drug-Resistant Epilepsy Market Import-Export Trade Statistics |
7.1 Thailand Drug-Resistant Epilepsy Market Export to Major Countries |
7.2 Thailand Drug-Resistant Epilepsy Market Imports from Major Countries |
8 Thailand Drug-Resistant Epilepsy Market Key Performance Indicators |
8.1 Average waiting time for epilepsy treatment in Thailand |
8.2 Number of epilepsy patients receiving specialized care |
8.3 Adoption rate of new technologies for epilepsy management in the country |
9 Thailand Drug-Resistant Epilepsy Market - Opportunity Assessment |
9.1 Thailand Drug-Resistant Epilepsy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Thailand Drug-Resistant Epilepsy Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Thailand Drug-Resistant Epilepsy Market - Competitive Landscape |
10.1 Thailand Drug-Resistant Epilepsy Market Revenue Share, By Companies, 2024 |
10.2 Thailand Drug-Resistant Epilepsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here